Robert W. Yeh, MD, MBA

The Director of the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology at the Beth Israel Deaconess Medical Center, and Associate Professor of Medicine at Harvard Medical School, Dr. Yeh is the Associate Chief of Interventional Cardiology and directs the Complex Coronary Intervention Program at Beth Israel Deaconess Medical Center. His research focuses on the evaluation of cardiovascular devices and therapies in both clinical trials and observational studies, with an emphasis on understanding methods to improve the value of novel technologies as they are used in clinical practice.

In his work at the Baim Institute, Dr. Yeh was one of the leaders of the Dual Antiplatelet Therapy (DAPT Study), an international multicenter randomized clinical trial, and led the creation of the DAPT Score, a guideline endorsed bedside tool useful for making individualized decisions regarding antiplatelet duration in patients undergoing stent procedures. Dr. Yeh also is the principal investigator of the Extending Trial‐Based Evaluations of Medical Therapies Using Novel Sources of Data Study, funded by the NIH, which validated the use of pragmatically collected hospital and administrative data for use in randomized clinical trials. Dr. Yeh has extensive experience working with registries, including the American College of Cardiology’s National Cardiovascular Data Registries, and administrative claims databases, such as data from the Centers for Medicare and Medicaid Services.

After medical school at Harvard, Dr. Yeh completed a residency at Massachusetts General Hospital, fellowships at UCSF and Mass General, a Master’s degree in Health Policy from the University of London, and a MBA from Oxford University.